U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H5NS
Molecular Weight 75.133
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIOACETAMIDE

SMILES

CC(N)=S

InChI

InChIKey=YUKQRDCYNOVPGJ-UHFFFAOYSA-N
InChI=1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4)

HIDE SMILES / InChI

Molecular Formula C2H5NS
Molecular Weight 75.133
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status.
2004-02
Sonochemical fabrication and characterization of stibnite nanorods.
2003-10-06
Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70.
2003-09-15
Lethal hepatic injury by combined treatment of radiation plus chemotherapy in rats with thioacetamide-induced liver cirrhosis.
2003-09-01
Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy.
2003-09
Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model.
2003-08
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
2003-08
Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.
2003-07
Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy.
2003-06
Differentially expressed genes in the liver of thioacetamide treated rats.
2003-06
Impact of endothelin-1 on microcirculatory disturbance after partial hepatectomy under ischemia/reperfusion in thioacetamide-induced cirrhotic rats.
2003-05-01
Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680].
2003-05
Zinc supplementation attenuates thioacetamide-induced liver injury and hyperglycemia in mice.
2003-05
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice.
2003-05
The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat.
2003-05
Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity.
2003-04-15
Expression of growth hormone receptor and its mRNA in hepatic cirrhosis.
2003-04
Mechanisms of increased liver tissue repair and survival in diet-restricted rats treated with equitoxic doses of thioacetamide.
2003-04
A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor.
2003-03-07
Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
2003-02
Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.
2003-02
Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression.
2003-01-13
A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure.
2003-01-03
Emergence of different macrophage populations in hepatic fibrosis following thioacetamide-induced acute hepatocyte injury in rats.
2003-01
Following the formation of nanometer-sized clusters by time-resolved SAXS and EXAFS techniques.
2003
Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation.
2002-12-20
Usefulness of the tactile sensor for estimating the degree of liver fibrosis and the DNA synthesis activity of remnant liver cells after partial hepatectomy.
2002-12
Changes in expression of cell cycle regulators after G1 progression upon repetitive thioacetamide treatment in rat liver.
2002-11-30
Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats.
2002-11
Hepatic stimulator substance activity in animal model of fulminant hepatic failure and encephalopathy.
2002-10
Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge.
2002-10
Immunohistochemical studies on the expression pattern of molecular chaperones HSC70 and HSP25 and cell cycle-related proteins cyclin D1 and PCNA in rat liver after thioacetamide intoxication.
2002-10
Tolerance to intermittent ischemia of damaged rat liver by thioacetamide.
2002-09-21
Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity.
2002-09-10
Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats.
2002-09
Hepatocyte ploidy in regenerating livers after partial hepatectomy, drug-induced necrosis, and cirrhosis.
2002-08-13
Thioacetamide impairs retinol storage and dolichol content in rat liver cells in vivo.
2002-08-08
Aminoguanidine, an inducible nitric oxide synthase inhibitor, plus N-acetylcysteine treatment reduce the lipopolysaccharide-augmented hepatotoxicity in rats with cirrhosis.
2002-07
Dolichol content in isolated sinusoidal liver cells after in vivo chronic treatment with thioacetamide.
2002-07
Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver.
2002-07
Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
2002-06-18
Alpha-glutathione S-transferase in the assessment of hepatotoxicity--its diagnostic utility in comparison with other recognized markers in the Wistar Han rat.
2002-06-08
Alterations to hepatic microcirculation in thioacetamide-induced cirrhotic livers of rats.
2002-06
[Experimental portal hypertensive colopathy in rats with liver cirrhosis].
2002-06
Changes in serum hyaluronic acid levels and expression of CD44 and CD44 mRNA in hepatic sinusoidal endothelial cells after major hepatectomy in cirrhotic rats.
2002-06
Effects of ammonia and hepatic failure on the net efflux of endogenous glutamate, aspartate and taurine from rat cerebrocortical slices: modulation by elevated K+ concentrations.
2002-05-22
Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose of thioacetamide.
2002-05-21
Level of superoxide dismutase, glutathione peroxidase and uric acid in thioacetamide-induced cirrhotic rats.
2002-04
Influence of aging on the carcinogen-induced protein kinase activity in rat liver cell nuclei.
2002-03
[Synthesis, preliminary antigastrelcosis activity and the protective effect on acute liver injury of zinc chlorin E4].
2001-03
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:54:41 GMT 2025
Edited
by admin
on Mon Mar 31 18:54:41 GMT 2025
Record UNII
075T165X8M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-2120
Preferred Name English
THIOACETAMIDE
HSDB   MI  
Systematic Name English
THIOACETAMIDE [IARC]
Common Name English
THIOACETAMIDE [MI]
Common Name English
THIOACETAMIDE [HSDB]
Common Name English
ACETOTHIOAMIDE
Systematic Name English
ETHANETHIOAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C45175
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
IARC Thioacetamide
Code System Code Type Description
PUBCHEM
2723949
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
NCI_THESAURUS
C44454
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
NSC
2120
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
FDA UNII
075T165X8M
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
HSDB
1318
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
CHEBI
32497
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
SMS_ID
300000053655
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
DAILYMED
075T165X8M
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-541-4
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
MERCK INDEX
m10742
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
THIOACETAMIDE
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
CAS
62-55-5
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
MESH
D013853
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID9021340
Created by admin on Mon Mar 31 18:54:41 GMT 2025 , Edited by admin on Mon Mar 31 18:54:41 GMT 2025
PRIMARY